S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
Log in
OTCMKTS:GNWSD

StageZero Life Sciences Stock Forecast, Price & News

$0.96
-0.18 (-15.83 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.88
Now: $0.96
$0.96
50-Day Range
$0.57
MA: $0.80
$1.27
52-Week Range
$0.17
Now: $0.96
$0.89
Volume36,712 shs
Average Volume4,987 shs
Market Capitalization$46.85 million
P/E RatioN/A
Dividend YieldN/A
Beta2.97
StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall in 1998 and is headquartered in Markham, Canada.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:GNWSD
CUSIPN/A
CIKN/A
Phone(855) 420-7140
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$140,000.00
Book Value($0.13) per share

Profitability

Net Income$-3,480,000.00

Miscellaneous

Market Cap$46.85 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1877th out of 1,960 stocks

Diagnostic Substances Industry

31st out of 32 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.96
-0.18 (-15.83 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GNWSD News and Ratings via Email

Sign-up to receive the latest news and ratings for GNWSD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











StageZero Life Sciences (OTCMKTS:GNWSD) Frequently Asked Questions

What stocks does MarketBeat like better than StageZero Life Sciences?

Wall Street analysts have given StageZero Life Sciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but StageZero Life Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are StageZero Life Sciences' key executives?

StageZero Life Sciences' management team includes the following people:
  • James R. Howard-Tripp, Executive Chairman & Chief Executive Officer
  • Rebecca Greco, Head-Investor Relations

Who are some of StageZero Life Sciences' key competitors?

What is StageZero Life Sciences' stock symbol?

StageZero Life Sciences trades on the OTCMKTS under the ticker symbol "GNWSD."

How do I buy shares of StageZero Life Sciences?

Shares of GNWSD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is StageZero Life Sciences' stock price today?

One share of GNWSD stock can currently be purchased for approximately $0.96.

How much money does StageZero Life Sciences make?

StageZero Life Sciences has a market capitalization of $46.85 million and generates $140,000.00 in revenue each year.

What is StageZero Life Sciences' official website?

The official website for StageZero Life Sciences is www.stagezerolifesciences.com.

Where are StageZero Life Sciences' headquarters?

StageZero Life Sciences is headquartered at 70 East Beaver Creek Road Unit 30, Richmond Hill A6, L4B 3B2.

How can I contact StageZero Life Sciences?

StageZero Life Sciences' mailing address is 70 East Beaver Creek Road Unit 30, Richmond Hill A6, L4B 3B2. The company can be reached via phone at (855) 420-7140 or via email at [email protected]


This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.